Pet/mri (axumin) study of men with highly suspicious mri lesions that showed no clinically signiciant prostate cancer following mri fusion targeted biopsy

Condition:   Prostate Cancer Intervention:   Diagnostic Test: Fluciclovine PET/MRI Sponsor:   New York University School of Medicine Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials